טוען...
Novel therapies for severe asthma in children and adults
The heterogeneous nature of asthma requires personalised treatments. Monoclonal antibody treatments showed good efficacy, and should be considered when symptoms are poorly controlled despite good inhaler technique, compliance and controlled comorbidities. http://ow.ly/UWpg30hImQh
שמור ב:
| הוצא לאור ב: | Breathe (Sheff) |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
European Respiratory Society
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5831346/ https://ncbi.nlm.nih.gov/pubmed/29515670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/20734735.018917 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|